Abstract:Background: Traumatic brain injury (TBI) is a major cause of morbidity and mortality, affecting millions annually worldwide. Although the majority of TBI patients return to premorbid baseline, a subset of patient can develop persistent and often debilitating neurocognitive and behavioral changes. The etiology of TBI within the clinical setting is inherently heterogenous, ranging from sport related injuries, fall related injuries and motor vehicle accidents in the civilian setting, to blast injuries in the military setting. Objective: Animal models of TBI, offer the distinct advantage of controlling for injury modality, duration and severity. Furthermore, preclinical models of TBI have provided the necessary temporal opportunity to study the chronic neuropathological sequelae of TBI, including neurodegenerative sequelae such as tauopathy and neuroinflammation within the finite experimental timeline. Despite the high prevalence of TBI, there are currently no disease modifying regimen for TBI, and the current clinical treatments remain largely symptom based. The preclinical models have provided the necessary biological substrate to examine the disease modifying effect of various pharmacological agents and have imperative translational value. Methods: The current review will include a comprehensive survey of well-established preclinical models, including classic preclinical models including weight drop, blast injury, fluid percussion injury, controlled cortical impact injury, as well as more novel injury models including closed-head impact model of engineered rotational acceleration (CHIMERA) models and closed-head projectile concussive impact model (PCI). In addition to rodent preclinical models, the review will include an overview of other species including large animal models and Drosophila . Results: There are major neuropathological perturbations post TBI captured in various preclinical models, which include neuroinflammation, calcium dysregulation, tauopathy, mitochondrial dysfunction and oxidative stress, axonopathy, as well as glymphatic system disruption. Conclusion: The preclinical models of TBI continue to offer valuable translational insight, as well as essential neurobiological basis to examine specific disease modifying therapeutic regimen.

Traumatic Brain Injury: a Review of Characteristics, Molecular Basis and Management.

Military Traumatic Brain Injury: a Challenge Straddling Neurology and Psychiatry

Traumatic brain injury: molecular biomarkers, genetics, secondary consequences, and medical management

Animal Models of Traumatic Brain Injury and Assessment of Injury Severity

Traumatic Brain Injury: A Comprehensive Review of Biomechanics and Molecular Pathophysiology

[Injury mechanism, clinical status and prospects of traumatic brain injury]

Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions

Neuroimmune and Neuroinflammation Response for Traumatic Brain Injury

Traumatic Brain Injury: Mechanistic Insight on Pathophysiology and Potential Therapeutic Targets

'Comprehensive review of emerging drug targets in traumatic brain injury (TBI): challenges and future scope

Prospects for Nerve Regeneration and Gene Therapy in the Treatment of Traumatic Brain Injury

Animal models of traumatic brain injury: a review of pathophysiology to biomarkers and treatments

Management and Treatment of Traumatic Brain Injuries

Acute traumatic brain injury: is current management evidence based? An empirical analysis of systematic reviews.

Neuroinflammation Following Traumatic Brain Injury: Take It Seriously or Not

An overview of preclinical models of traumatic brain injury (TBI): relevance to pathophysiological mechanisms

Progress in research on bio-molecular markers of traumatic brain injury

A Systematic Review of Traumatic Brain Injury in Modern Rodent Models: Current Status and Future Prospects

Comprehensive RNA Expression Analysis Revealed Biological Functions of Key Gene Sets and Identified Disease-Associated Cell Types Involved in Rat Traumatic Brain Injury

Pathogenesis and management of traumatic brain injury (TBI): role of neuroinflammation and anti-inflammatory drugs

Bioinformatics-based Identification of Key Pathways and Hub Genes of Traumatic Brain Injury in a Rat Model